A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

E-Zyvec, a France-based producer of fully customised gene expression vectors spun out of University of Lille, has been acquired by nucleic acid transfection solutions provider PolyPlus for an undisclosed amount. The spinout was founded in 2016 with the support of regional tech transfer office SATT Nord and raised an undisclosed amount of seed funding two years later from Autonomie et Solidarité, Nord France Amorçage and unnamed individuals. In December 2020, the spinout attracted €1.4m ($1.6m) in a series A round from an unnamed biotechnology company and state-owned investment bank Bpifrance.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).